NAVRÁTILOVÁ, Jarmila, Tereza HANKEOVÁ, Petr BENEŠ and Jan ŠMARDA. Low-Glucose Conditions of Tumor Microenvironment enhance cytotoxicity of tetrathiomolybdate to neuroblastoma cells. Nutrition and Cancer. 2013, vol. 65, No 5, p. 702-710. ISSN 0163-5581. Available from: https://dx.doi.org/10.1080/01635581.2013.789118.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Low-Glucose Conditions of Tumor Microenvironment enhance cytotoxicity of tetrathiomolybdate to neuroblastoma cells
Authors NAVRÁTILOVÁ, Jarmila (203 Czech Republic, belonging to the institution), Tereza HANKEOVÁ (203 Czech Republic, belonging to the institution), Petr BENEŠ (203 Czech Republic, belonging to the institution) and Jan ŠMARDA (203 Czech Republic, guarantor, belonging to the institution).
Edition Nutrition and Cancer, 2013, 0163-5581.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10601 Cell biology
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 2.635
RIV identification code RIV/00216224:14310/13:00065615
Organization unit Faculty of Science
Doi http://dx.doi.org/10.1080/01635581.2013.789118
UT WoS 000321887700010
Keywords in English tetrathiomolybdate; neuroblastoma; glucose starvation; apoptosis; cancer therapy
Tags AKR
Changed by Changed by: doc. Mgr. Petr Beneš, Ph.D., učo 2082. Changed: 19/2/2018 10:06.
Abstract
Growth of tumor cells depends on sufficient supply of fermentable substrate, such as glucose. This provokes development of new anti-cancer therapies based on dietary restrictions. However, some tumor cells can lower their glucose dependency and activate processes of ATP formation/saving to retain viability even in limited glucose supply. In addition, tumor cells often loose sensitivity to many conventional anti-cancer drugs in the low-glucose conditions. Thus, development of the drugs effectively killing the tumor cells in nutrient-limited conditions is necessary. In this study, we show an enhanced cytotoxicity of tetrathiomolybdate, the drug exhibiting anti-angiogenic and tumor-suppressing effects, to neuroblastoma SH-SY5Y and SK-N-BE(2) cells in the low-glucose conditions. This preference results from the tetrathiomolybdate-induced upregulation of cell dependency on glucose. The cells treated with tetrathiomolybdate increase the uptake of glucose, production of lactate, activate the Akt- and AMPK signaling pathways and down-regulate COX IV. In cells growing in the low-glucose conditions, these events result in significant decrease of the intracellular ATP supply and apoptosis. We propose TM as suitable agent to be used in combination with dietary restrictions in therapy of neuroblastoma.
Links
CZ.1.07/2.3.00/20.0097, interní kód MUName: IntegRECAMO: Intellectual Anchor (Acronym: IntegRECAMO)
Investor: Ministry of Education, Youth and Sports of the CR, 2.3 Human resources in research and development
GA301/09/1115, research and development projectName: Úloha proteinů c-Myb a Cox-2 při tvorbě střevních nádorů
Investor: Czech Science Foundation, The role of c-Myb and Cox-2 proteins in colon carcinogenesis
NT13441, research and development projectName: Exprese proteinů rodiny Myb v adenokarcinomech tlustého střeva a vztah k jejich metastatickému potenciálu
PrintDisplayed: 19/7/2024 01:41